# A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas

> **NCT01130077** · PHASE1 · COMPLETED · sponsor: **James Felker** · enrollment: 60 (estimated)

## Conditions studied

- Newly Diagnosed Pediatric Pontine Glioma
- Newly Diagnosed Pediatric High Grade Glioma
- Recurrent Pediatric High Grade Glioma
- Recurrent Pediatric Low Grade Glioma

## Interventions

- **BIOLOGICAL:** HLA-A2 restricted glioma antigen peptides vaccine
- **BIOLOGICAL:** Poly-ICLC

## Key facts

- **NCT ID:** NCT01130077
- **Lead sponsor:** James Felker
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-11-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-12-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01130077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01130077, "A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01130077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*